Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Whitehawk Therapeutics Inc (WHWK)

Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 PR Newswire - Sun Apr 19, 5:00PM CDT

Data demonstrate preclinical proof-of-concept for HWK-007, HWK-016 and HWK-206, underpinned by Whitehawk's proprietary Carbon Bridge Cysteine Re-pairing platform

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series PR Newswire - Thu Apr 16, 3:05PM CDT

MORRISTOWN, N.J. , April 16, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor...

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 PR Newswire - Fri Apr 10, 6:00AM CDT

MUC16 is the highest-expressing ADC target in ovarian cancer, at least two-fold higher than other emerging targets

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 PR Newswire - Tue Mar 17, 3:30PM CDT

MORRISTOWN, N.J. , March 17, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor...

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights PR Newswire - Thu Mar 12, 7:00AM CDT

Actively recruiting Phase 1 trials for PTK7-targeted antibody-drug conjugate (ADC) HWK-007 and MUC16-targeted ADC HWK-016

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences PR Newswire - Thu Feb 26, 7:00AM CST

MORRISTOWN, N.J. , Feb. 26, 2026 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), a clinical-stage oncology therapeutics company applying advanced technologies to established tumor biology...

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 PR Newswire - Thu Jan 8, 7:00AM CST

Actively recruiting Phase 1 trial for PTK7-targeted antibody-drug conjugate (ADC) HWK-007

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer PR Newswire - Mon Dec 1, 2025

Dr. Dugan brings extensive clinical development leadership to Whitehawk as ADC programs near the clinic

WHWK : 4.13 (-2.36%)
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference PR Newswire - Wed Nov 26, 2025

MORRISTOWN, N.J. , Nov. 26, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently...

WHWK : 4.13 (-2.36%)
AI-Powered Platforms Scale as Preventive Care and Biomarker Testing Converge BayStreet.ca - Tue Nov 18, 2025

VANCOUVER – Baystreet.ca News Commentary – Healthcare providers are prioritizing preventive care strategies as nearly 58% now integrate biomarker testing into early wellness indicators [1], a shift...

HIMS : 28.15 (-2.96%)
TEM : 51.03 (-8.07%)
WHWK : 4.13 (-2.36%)
BFLY : 5.22 (-5.61%)
ALEN-U.CN : 0.9800 (unch)

Barchart Exclusives

UnitedHealth Is Back! But Should You 'Long-Term Care' About UNH Stock? Barchart - 37 minutes ago
UnitedHealth reported Q1 earnings earlier this week, and it's a comeback story worth watching. Here's what to know. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.